Clinical Collaboration

Selected news for the healthcare topic - Clinical Collaboration, collected since 10/2017. This healthcare topic shares news with Merck, Bristol-Myers, Bristol-Myers Squibb, Gilead, Prostate Cancer and over a hundred others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
10/19/2021 NeoGenomics' Liquid Biopsy Subsidiary Inivata Announces Clinical Collaboration With Princess Margaret Cancer Center for the Use of Its Liquid Biopsy Assays illinoisintelligencer.com ... NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that its liquid biopsy focused subsidiary Inivata Limited ('Inivata') has entered into a clinical collaboration with the Princess Margaret Cancer Center in Toronto, Canada, for the use of Inivata's liquid biopsy assays, InVisionFirst®-Lung and RaDaR™ in two separate studies.The Accelerating Lung Cancer Diagnosis through Liquid ...
10/19/2021 Two clinical studies including interventional RaDa wapakdailynews.com ... NeoGenomics, Inc. ( NASDAQ:NEO ), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that its liquid biopsy focused subsidiary Inivata Limited ("Inivata") has entered into a clinical collaboration with the Princess Margaret Cancer Center in Toronto, Canada, for the use of Inivata's liquid biopsy assays, InVisionFirst®-Lung and RaDaR™ in two separate studies.The Accelerating Lung Cancer Diagnosis through Liquid ...
10/19/2021 NeoGenomics' Liquid Biopsy Subsidiary Inivata Announces Clinical Collaboration With Princess Margaret Cancer Center for the Use of Its Liquid Biopsy Assays neogenomics.com ... NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that its liquid biopsy focused subsidiary Inivata Limited ("Inivata") has entered into a clinical collaboration with the Princess Margaret Cancer Center in Toronto, Canada, for the use of Inivata's liquid biopsy assays, InVisionFirst®-Lung and RaDaR™ in two separate studies. The Accelerating Lung Cancer Diagnosis through Liquid ...
10/19/2021 NeoGenomics' Liquid Biopsy Subsidiary Inivata Announces Clinical Collaboration With Princess Margaret Cancer Center for the Use of Its Liquid Biopsy Assays portlandnews.net ... NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that its liquid biopsy focused subsidiary Inivata Limited ('Inivata') has entered into a clinical collaboration with the Princess Margaret Cancer Center in Toronto, Canada, for the use of Inivata's liquid biopsy assays, InVisionFirst®-Lung and RaDaR™ in two separate studies.The Accelerating Lung Cancer Diagnosis through Liquid ...
10/19/2021 Inivata Announces Clinical Collaboration with Princess Margaret Cancer Center for the use of its Liquid Biopsy Assays Globe Newswire Inivata Announces Clinical Collaboration with Princess Margaret Cancer Center for theuse of its Liquid Biopsy AssaysTwo clinical studies including interventional RaDaR™ studyResearch Triangle Park, NC, USA and Cambridge, UK, 19 October 2021 -- Inivata, a leader in liquid biopsy, today announced a clinical collaboration with the Princess Margaret Cancer Center in Toronto, Canada, for the use of Inivata’s liquid biopsy assays, InVisionFirst®-Lung and RaDaR ...
10/13/2021 Everbridge Wins 2021 Stratus Award for Its Industry-Leading Healthcare Solution Enabling Hospitals and Health Systems to Improve Secure Clinical Collaboration Yahoo News ... press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211013005663/en/Everbridge Wins 2021 Stratus Award for Its Industry-Leading Healthcare Solution Enabling Hospitals and Health Systems to Improve Secure Clinical Collaboration (Photo: Business Wire)"We rely on the cloud for everything from personal health to organizational productivity, and we are proud to recognize Everbridge’s place at the forefront of innovation," said Maria Jimenez, Chief ...
10/13/2021 Turning Point Therapeutics and EQRx Announce Clinical Collaboration to Evaluate Elzovantinib in Combination with Aumolertinib in Patients with EGFR Mutant Met-Amplified Advanced Non-Small Cell Lung Cancer Globe Newswire ... next-generation therapies that target genetic drivers of cancer, and EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices, today announced a clinical collaboration to evaluate elzovantinib (TPX-0022), Turning Point’s drug candidate targeting MET, SRC, and CSF1R, in combination with aumolertinib, EQRx’s drug candidate targeting EGFR, in patients with EGFR mutant MET-amplified advanced non ...
10/13/2021 Turning Point Therapeutics and EQRx Announce Clinical Collaboration to Evaluate Elzovantinib in Combination with Aumolertinib in Patients with EGFR Mutant Met-Amplified Advanced Non-Small Cell Lung Cancer firstwordpharma.com ... next-generation therapies that target genetic drivers of cancer, and EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices, today announced a clinical collaboration to evaluate elzovantinib (TPX-0022), Turning Point's drug candidate targeting MET, SRC, and CSF1R, in combination with aumolertinib, EQRx's drug candidate targeting EGFR, in patients with EGFR mutant MET-amplified advanced non-small cell ...
10/13/2021 Everbridge Wins 2021 Stratus Award for Its Industry-Leading Healthcare Solution Enabling Hospitals and Health Systems to Improve Secure Clinical Collaboration digitalmedianet.com Everbridge Wins 2021 Stratus Award for Its Industry-Leading Healthcare Solution Enabling Hospitals and Health Systems to Improve Secure Clinical Collaboration Published Date: October 13, 2021 Over 1,500 healthcare entities rely on Everbridge’s HIPAA-compliant clinical communication and collaboration software to enable enterprise resilienceBURLINGTON, Mass.–(BUSINESS WIRE)– Everbridge , Inc. (NASDAQ: EVBG), the global leader in critical event management ( CEM ), today announced that its best-in-class ...
10/12/2021 CG Oncology to Present Two Programs at The Society for Immunotherapy of Cancer (SITC) 2021 Annual Meeting Yahoo News ... Phase 2 clinical trial of CG0070 in combination with KEYTRUDA® (pembrolizumab), for the treatment of patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG).Under a previously announced clinical collaboration with Merck relating to the investigation of CG0070 used in combination with pembrolizumab, the goal of CORE1, which will enroll up to 35 patients, is to evaluate the safety and efficacy of CG0070 plus ...
10/12/2021 CG Oncology to Present Two Programs at The Society for Immunotherapy of Cancer (SITC) 2021 Annual Meeting | Financial Buzz financialbuzz.com ... Phase 2 clinical trial of CG0070 in combination with KEYTRUDA® (pembrolizumab), for the treatment of patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG).Under a previously announced clinical collaboration with Merck relating to the investigation of CG0070 used in combination with pembrolizumab, the goal of CORE1, which will enroll up to 35 patients, is to evaluate the safety and efficacy of CG0070 plus ...
10/8/2021 Humana's hire portends big things for its primary care business Modern Healthcare ... care arms, which include the CenterWell Senior Primary Care brand and Conviva Care Centers. He will report to Renee Buckingham, segment president of primary care at Humana."Dr. Garg's advanced expertise in patient care, clinical collaboration and innovative care delivery will be instrumental in our continued success," Buckingham said in a news release. "His commitment to both our model—a whole-person approach including physical health, mental wellbeing, and social ...
10/8/2021 Can Adopting Cloud-Based Solutions Create More Agile Healthcare Systems? tigerconnect.com ... text message to say you’re running late for dinner. Simple, direct communication. Now, think about the last time that you communicated with a patient. Not exactly simple, is it? Cloud-based solutions like clinical collaboration platforms simplify patient communication benefiting, both patients and providers. In the latest episode of PSQH: The Podcast, Dr. Will O’Connor, CMIO at TigerConnect, discusses how cloud-based solutions can dramatically improve the way ...
10/6/2021 Should You Buy the Dip in Palantir? By StockNews streetregister.com ... October 4, the National Institutes of Health (NIH), National Center for Advancing Translational Sciences, (NCATS), awarded a contract for PLTR to provide a cloud-based secure data enclave that centralizes COVID-19 data for clinical collaboration . Foundry for Builders was also launched by the company on July 20. Stock has grown by 157% in the past one year. It has fallen 13% and 5% respectively over the last month. It ...
10/4/2021 What We Learned From KLAS Research Clinical Communication Platforms 2021 Report tigerconnect.com At TigerConnect, it’s been evident to us for a long time that Clinical Collaboration is no longer an aspiration for healthcare systems; it’s an imperative. COVID-19 intensified this reality. Care team members, facing all-time high rates of burnout and being routinely pushed to their limits, need effective collaboration tools–beyond simple secure messaging. But it is more than this. Healthcare organizations that have invested in more ...
10/1/2021 TigerConnect Highlighted in KLAS Research 2021 Report on Clinical Communication Platforms for Ease of Use Yahoo News ... TigerConnect.TigerConnect (PRNewsfoto/TigerConnect) Following in the footsteps of a year marked by significant feature enhancements and the company's acquisitions of on-call physician scheduling and advanced middleware solutions , TigerConnect bolstered the company's core Clinical Collaboration Platform and deepened its capabilities."2021 has proven a tipping point as healthcare systems evolve their requirements from secure messaging to the most contextual, advanced clinical collaboration experiences. Clinicians are demanding an all-in ...
10/1/2021 TigerConnect Highlighted in KLAS Research 2021 Report on Clinical Communication Platforms for Ease of Use tmcnet.com ... workflows provided by TigerConnect.Following in the footsteps of a year marked by significant feature enhancements and the company's acquisitions of on-call physician scheduling and advanced middleware solutions , TigerConnect bolstered the company's core Clinical Collaboration Platform and deepened its capabilities."2021 has proven a tipping point as healthcare systems evolve theirrequirements from secure messaging to the most contextual, advanced clinical collaboration experiences. Clinicians are demanding an all-in-one ...
9/28/2021 Transforming Workflows with Role-Based Communication at St. Luke's tigerconnect.com ... network saw a need for improving care team coordination within its organization. St. Luke’s partnered with TigerConnect to leverage modern communication tools and streamline its overall communications strategy. Through integration with the TigerConnect Clinical Collaboration platform, the health network implemented role-based communication to optimize workflows and accelerate decision-making for better patient care. Learn how the health network leveraged role-based communication to support more efficient clinical operations ...
9/23/2021 BofA Securities lifts Nektar Therapeutics [NKTR] price estimate. Who else is bullish? dbtnews.com Nektar Therapeutics [NASDAQ: NKTR] stock went on an upward path that rose over 0.34% on Wednesday, amounting to a one-week price increase of more than 9.89%. The company report on September 21, 2021 that Nektar Announces New Clinical Collaboration with Merck KGaA Darmstadt, Germany and Pfizer Inc. to Combine NKTR-255, a Novel Interleukin-15 Agonist, with Avelumab in the JAVELIN Bladder Medley Study. Nektar Therapeutics (NASDAQ: NKTR) announced ...
9/22/2021 Riding the Trend or Protecting Profits | Nektar Therapeutics (NKTR) newsheater.com ... to the recent 1-year high of $26.75. The company’s stock price has collected 10.96% of gains in the last five trading sessions. Press Release reported 13 hours ago that Nektar Announces New Clinical Collaboration with Merck KGaA Darmstadt, Germany and Pfizer Inc. to Combine NKTR-255, a Novel Interleukin-15 Agonist, with Avelumab in the JAVELIN Bladder Medley Study Is It Worth Investing in Nektar Therapeutics (NASDAQ :NKTR ...